Inventor · disambiguated record
Rima Al-Awar
Also filed as: AL-AWAR RIMA · AL-AWAR RIMA S · AL-AWAR RIMA SALIM
11 granted patents·5 pending applications·74 citations·filing 1997–2023
86Inventor score
Files withONTARIO INSTITUTE FOR CANCER RES OICR7LILLY CO ELI4PROPELLON THERAPEUTICS INC4SUNNYBROOK RES INST1
Top patents by PatentIndex Score
16 records- 0182US6867198B2Agents and methods for the treatment of proliferative diseasesLILLY CO ELI·Filed 2000·Granted Mar 15, 2005·15 cites·8 claims
- 0280US11518764B2Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interactionONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2019·Granted Dec 6, 2022·3 cites·18 claims
- 0379US11576981B2Acyl hydrazone linkers, methods and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2018·Granted Feb 14, 2023·1 cites·20 claims
- 0479US11174250B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted Nov 16, 2021·3 cites·23 claims
- 0577US6680311B1Cryptophycin compoundsLILLY CO ELI·Filed 1997·Granted Jan 20, 2004·48 cites·21 claims
- 0668US11319299B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted May 3, 2022·1 cites·39 claims
- 0762US2025154140A1Isoquinoline derivatives as inhibitors of bax and/or bak, compositions and uses thereofSUNNYBROOK RES INST·Filed 2023·Application pending·0 cites
- 0861US12264147B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·2 claims
- 0960US6743785B2Agents and methods for the treatment of proliferative diseasesLILLY CO ELI·Filed 2000·Granted Jun 1, 2004·2 cites·10 claims
- 1056US7414063B2Inhibitors of Akt (protein kinase B)LILLY CO ELI·Filed 2004·Granted Aug 19, 2008·1 cites·12 claims
- 1154US2024317723A1Substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 1253US2024092763A1Isoindolinone aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 1353US2024025887A1Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 1449US11850287B2Heterocyclic acyl hydrazone linkers, methods and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2018·Granted Dec 26, 2023·0 cites·19 claims
- 1545US2020385371A1Inhibitors of wdr5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1642US11242351B2Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2018·Granted Feb 8, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Rima Al-Awar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →